+4415180811362024: Volume 9, Issue 6
Editorial P.1-2
Integrating Multimodal Therapy for Optimized Cancer Treatment: A Comprehensive Review
Author(s):
Mary Peters
DOI: 10.35841/jmot-9.6.231
Opinion Article P.1-2
Comparative Efficacy of Multimodal Therapy in Early Versus Advanced-Stage Cancers
Author(s):
Kristin Croke
DOI: 10.35841/jmot-9.6.232
Short Communication P.1-2
Challenges and Future Directions in the Development of Monoclonal Antibodies for Solid Tumor Therapy
Author(s):
Jose Talcott
DOI: 10.35841/jmot-9.6.233
Rapid Communication P.1-2
Checkpoint Inhibitors in Cancer Immunotherapy: Current Status and Future Directions
Author(s):
Kerry Barac
DOI: 10.35841/jmot-9.6.234
Editorial P.1-2
Palliative Care in Oncology: Improving Quality of Life for Patients with Advanced Cancer
Author(s):
Jonathan Martin
DOI: 10.35841/jmot-9.6.235
Opinion Article P.1-2
Environmental and Genetic Factors in Carcinogenesis: A Pathway to Personalized Cancer Risk Assessment
Author(s):
Julie Malkani
DOI: 10.35841/jmot-9.6.236
Short Communication P.1-2
Barriers to Palliative Care in Oncology: Addressing the Gaps in Patient-Centered Care
Author(s):
Rupert Aapro
DOI: 10.35841/jmot-9.6.237
Rapid Communication P.1-2
Understanding the Molecular Mechanisms of Carcinogenesis: Implications for Cancer Prevention
Author(s):
Daniel Bartsch
DOI: 10.35841/jmot-9.6.238
Editorial P.1-2
Checkpoint Blockade: Revolutionizing Cancer Treatment through Immune System Modulation
Author(s):
Shannon Plante
DOI: 10.35841/jmot-9.6.239
Opinion Article P.1-2
Monoclonal Antibodies in Cancer Therapy: Mechanisms, Targets, and Clinical Applications
Author(s):
Joel Fortin
DOI: 10.35841/jmot-9.6.240